By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic announced on Monday afternoon a consolidation of its R&D activities and a reduction in headcount as net sales for the third quarter fell 12 percent.

For the three months ended Sept. 30, the Omaha, Neb.-based company said sales shrank to $4.4 million, compared to $5.0 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.